Best-ms: a standardized and prospective study comparing the efficacy of natalizumab versus fingolimod in active relapsing multiple sclerosis

Affiliation auteurs!!!! Error affiliation !!!!
TitreBest-ms: a standardized and prospective study comparing the efficacy of natalizumab versus fingolimod in active relapsing multiple sclerosis
Type de publicationJournal Article
Year of Publication2020
AuteursCohen M., Mondot L., Bucciarelli F., Pignolet B., Laplaud D., Brochet B., Defer G., Vermersch P., Debouverie M., Berger E., Labauge P., De Seze J., Brassat D., Lebrun-Frenay C.
JournalMULTIPLE SCLEROSIS JOURNAL
Volume26
Pagination210-211
Date PublishedDEC
Type of ArticleMeeting Abstract
ISSN1352-4585